Press Release: New York Times Supplement on Gynecologic Cancers to Provide Critical Women’s Health Information

Chicago, May 8, 2003—Women nationwide will have an opportunity to learn the latest information about gynecologic cancers through a four-page supplement appearing nationwide in The New York Times on Sunday, June 22, 2003. The supplement will also appear Tuesday, June 17 in copies of The New York Times distributed to subscribers in the New York designated market only.

Sponsored by the Gynecologic Cancer Foundation (GCF), the supplement “Gynecologic Cancer—What Every Women Needs to Know,” will provide the latest information regarding risk factors, symptoms, detection methods and treatment options for gynecologic cancers.

“Millions of American women often lack timely and accurate information about testing and treatments for gynecologic cancers,” said Gynecologic Cancer Foundation Chairman Karl C. Podratz, M.D., Ph.D. “This supplement provides one more way for us to further raise awareness about critical women’s health issues. Since education leads to prevention, we believe this supplement can help strengthen our fight against gynecologic cancers.” Dr. Podratz is a professor of Obstetrics and Gynecology at the Mayo Clinic in Rochester, Minn.

The publication date of the GCF supplement was designed to coincide with the annual “Women’s Health” section of The New York Times that will be published on Sunday, June 22, 2003. This Sunday edition of the newspaper has a circulation of 1.7 million and is expected to have a readership of more than 3 million nationwide.

The Gynecologic Cancer Foundation will also distribute more than 10,000 copies of the supplement to members of the Society of Gynecologic Oncologists, women’s health organizations and cancer advocate groups worldwide. Additionally, the supplement will be featured on GCF’s Web site,, and the Women’s Cancer Network Web site—the premier site for women’s cancer information—at

“After the success of our 2002 supplement which appeared in The Washington Post, we are confident that by providing this important information, we can empower a vast audience of women to take risk-reducing measures when possible, and to seek timely and appropriate medical care should they find themselves experiencing any of the known symptoms for gynecologic cancer,” said Bobbie Gostout, M.D., Communications Chair for the GCF and Assistant Professor, Department of Gynecologic Surgery at the Mayo Clinic.


Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video


A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.


The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.